T1	Participants 145 167	rectal cancer patients
T2	Participants 323 329	rectal
T3	Participants 330 405	carcinoma patients without distant metastasis or peritoneal carcinomatosis.
T4	Participants 467 551	51 rectal carcinoma patients without distant metastasis or peritoneal carcinomatosis
T5	Participants 1436 1484	rectal carcinoma patients receiving radiotherapy
T6	Participants 1485 1510	either pre-operatively or
T7	Participants 1511 1527	postoperatively.
